LEIGC Long Non-Coding RNA Acts As a Tumor Suppressor in Gastric Carcinoma by Inhibiting the Epithelial-to-mesenchymal Transition

Yuehua Han,Jun Ye,Dang Wu,Pin Wu,Zhigang Chen,Jian Chen,Shunliang Gao,Jian Huang
DOI: https://doi.org/10.1186/1471-2407-14-932
IF: 4.638
2014-01-01
BMC Cancer
Abstract:Background: Long non-coding RNAs have been shown to have critical regulatory roles in cancer biology. However, the contributions of lncRNAs to gastric cancer remain largely unknown.Methods: The differential expression of lncRNAs in gastric cancer and paired non-cancerous tissues were identified by microarray and validated using quantitative real-time PCR. Gastric samples from patients with gastric cancer were further analyzed for levels of a specifically downregulated lncRNA (termed as LEIGC).Results: We found that there were significantly lower levels of LEIGC expression in cancer tissue than in adjacent non-cancerous tissues in human gastric cancers (P < 0.01). Overexpression of LEIGC suppressed tumor growth and cell proliferation, and enhanced the sensitivity of gastric cancer cells to 5-fluorouracil (5-FU), whereas knockdown of LEIGC showed the opposite effect. We further demonstrated LEIGC functions by inhibiting the epithelial-tomesenchymal transition (EMT) in gastric cancer.Conclusions: Our data suggested that LEIGC is a tumor-suppressing lncRNA in gastric cancer, and led us to propose that lncRNAs may play important regulatory roles in cancer development and progression.
What problem does this paper attempt to address?